Biolase, Inc. (BIOLQ) vs Nuwellis, Inc. (NUWE)
Biolase, Inc. and Nuwellis, Inc. are both Medical Devices companies. Nuwellis, Inc. is the larger, with a market value of $2.9M against $2.3M — 1.2× the size. Nuwellis, Inc. grew revenue faster over the last twelve months: 8.36% against −7.44%. Biolase, Inc. has the higher net margin (−71.8% vs −125.6%) and the lower return on invested capital (−109.5% vs 0.00%). Across the 16 metrics below, Biolase, Inc. leads on 10 and Nuwellis, Inc. on 6.
Valuation
Profitability
| Metric | BIOLQ | NUWE | Medical Devices median |
|---|---|---|---|
| Gross margin | 34.44% | 69.69% | 56.01% |
| Operating margin | (29.37%) | (142.87%) | (15.03%) |
| Net margin | (71.75%) | (125.57%) | (20.40%) |
| Free cash flow margin | (28.55%) | (140.67%) | (7.24%) |
| Return on equity | 1,349.30% | 205.50% | (15.32%) |
| Return on assets | (100.09%) | (123.52%) | (19.72%) |
| Return on invested capital | (109.48%) | 0.00% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack